MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 55131-55140 Newer>
The Motley Fool
January 17, 2012
Isaac Pino
Tech Stocks to Bet On in 2012 A Fool's take on stocks to buy, sell, and hold in the tech industry. mark for My Articles 632 similar articles
The Motley Fool
January 17, 2012
Dan Radovsky
Verizon and Comcast: Strange Bedfellows? The first joint marketing agreement between Verizon and Comcast has been launched. mark for My Articles 1159 similar articles
The Motley Fool
January 17, 2012
Rex Moore
Netgear Looks Nifty with These 2 Metrics Netgear appears to be in good shape in terms of its intangible assets ratio and tangible book value. mark for My Articles 331 similar articles
The Motley Fool
January 17, 2012
Anders Bylund
Netflix Scores a Supernatural Boost Twilight falls over Lionsgate. This is a very, very good thing. mark for My Articles 507 similar articles
The Motley Fool
January 17, 2012
Travis Hoium
Molycorp Still Bullish on Rare-Earth Minerals Molycorp's CEO gives his reasons for optimism in the sector. mark for My Articles 48 similar articles
The Motley Fool
January 17, 2012
Evan Niu
Why ARM Isn't Afraid of Intel Power efficiency is the name of the game in mobile. mark for My Articles 790 similar articles
The Motley Fool
January 17, 2012
Evan Niu
Was Zynga's IPO Good Enough? It's all a matter of perspective. mark for My Articles 64 similar articles
The Motley Fool
January 17, 2012
Rex Moore
Which Stock Can Pass This Tough Test? This month's Modified Foolish 8 screen. mark for My Articles 20 similar articles
The Motley Fool
January 17, 2012
Evan Niu
Apple's New Hobby The longer the patent war wages on, the more unsuccessful it appears. mark for My Articles 711 similar articles
The Motley Fool
January 17, 2012
Brian Orelli
You Can Forget About Seeing This Drug Work Medivation and Pfizer's Dimebon fails again. mark for My Articles 179 similar articles
<Older 55131-55140 Newer>    Return to current articles.